INTRODUCTION
Our perception of the world around us is dependent on the cortical processing of somatosensory, visual, and auditory sensory input which is relayed from the thalamus to the cortex. Cortical inhibition, mediated by local GABAergic interneurons (Porter et al. 2001) , plays a critical role in this processing by determining receptive field sizes and temporal interactions between adjoining receptive fields (Alloway et al. 1989; Dykes et al. 1984; Kyriazi et al. 1996b ). In addition, cortical inhibition plays a role in activityinduced plasticity (Hensch et al. 1998; Knott et al. 2002; Micheva and Beaulieu 1995; Welker et al. 1989) . For example in the rodent somatosensory system, repeated whisker stimulation induces a long-lasting increase in the number of inhibitory synapses in the corresponding cortical barrel (Knott et al. 2002) and in the enzyme glutamic acid decarboxylase which synthesizes GABA (Welker et al. 1989 ).
Cortical inhibition is mediated by the stimulation of GABA A receptors, which are ligand-gated chloride channels, and G protein-coupled GABA B receptors. Although many studies have focused on inhibition through GABA A receptors, several in vivo studies in the barrel cortex and other areas of the primary somatosensory cortex indicate that GABA B receptors also modulate the processing of thalamocortical inputs by regulating receptive field sizes and allowing for the temporal encoding of sensory inputs (Ajima et al. 1999; Chowdhury and Rasmusson 2002a , 2003 , 2002b Kaneko and Hicks 1988; Kaneko and Hicks 1990) . Mechanistically, this modulation could occur through the stimulation of presynaptic GABA B receptors on the thalamocortical axon terminals or postsynaptic GABA B receptors on the dendrites and cell bodies of the cortical neurons.
GABA B receptors exist on many glutamatergic terminals where they decrease the release of glutamate by inhibiting voltage-dependent Ca 2+ channels (VDCCs) and thus presynaptic calcium influx (Wu and Saggau 1995; Wu and Saggau 1997) and on dendrites and cell bodies where they activate inwardly rectifying K + channels to cause inhibition (Luscher et al. 1997; Sodickson and Bean 1996) . A previous study showed that GABA B receptor activation does not inhibit thalamocortical synapses onto layer II/III pyramidal neurons (Gil et al. 1997) suggesting that thalamocortical synapses are not presynaptically regulated by GABA B receptors. However, in the present study we demonstrate that presynaptic GABA B receptors exist at thalamocortical synapses onto inhibitory neurons in layer IV and excitatory neurons in layers II-III and IV of the mouse "barrel" cortex where they reduce the thalamic activation of cortical inhibition and excitation.
METHODS

Thalamocortical Slices
The were elicited with the injection of current pulses to distinguish between inhibitory and excitatory cells as previously described (Porter et al. 2001 Baclofen, bicuculline, AP5, CNQX, and MK-801 were purchased from Sigma (St.
Louis, MO). CGP 35348 was purchased from Tocris (Ellisville, MO).
Data analysis and statistics
Experiments were accepted for analysis if the effect of baclofen on the EPSCs reversed upon removal of the drug and there was no confounding di-or polysynaptic activity in the EPSCs. Data were analyzed using Clampfit (Axon Instruments, Union City, CA). To calculate the paired pulse ratio (PPR) for a given cell, the thalamus was stimulated with pairs of stimuli 50 ms apart and the mean amplitude of the EPSC generated by the second stimulus (EPSC2) was divided by the mean amplitude of the EPSC generated by the first stimulus (EPSC1). The average EPSCs were taken from ten 
Morphology
For post hoc morphological identification of inhibitory and excitatory cells 5 mM biocytin was included in the recording solution to label the neurons. Following the electrophysiological recordings, the slices were fixed and refrigerated overnight in 4%
paraformaldehyde, and the labeled neurons were subsequently revealed with a standard advidin-biotin peroxidase procedure (Vectastain ABC kit, Vector Laboratories, Burlingame, CA) as previously described (Porter et al. 2001) . Images of the labeled neurons were taken with a cooled CCD camera (CoolSNAPcf, Roper Scientific, Trenton, NJ) using a 40x objective on an upright microscope (Olympus America, Melville, NY).
RESULTS
GABA B receptors reduce thalamocortical excitation of excitatory and inhibitory neurons in layer IV of the barrel cortex.
Using the thalamocortical slice preparation (Agmon and Connors 1991), we examined the modulation of thalamic input onto inhibitory and excitatory cells in layer IV of the mouse barrel cortex by GABA B receptors in mice 10-23 days old. Inhibitory interneurons were distinguished from excitatory neurons by their action potential discharge patterns in response to injected depolarizing current pulses or post hoc morphology as previously described (Connors and Gutnick 1990; Porter et al. 2001 ).
Twenty seven neurons were identified by both discharge pattern and morphology. In each case the morphology confirmed the classification based on the discharge pattern.
Seventeen neurons were identified by action potential discharge pattern alone and 32 neurons were identified by morphology alone. To confirm that the studied EPSCs were of thalamocortical origin several different parameters were measured. The latency of the EPSCs was measured and the range and the coefficient of variation of the latencies were calculated. Previous studies have demonstrated that monosynaptic thalamocortical EPSCs exhibit latencies which vary by less than 1 ms (Agmon et al. 1996; Beierlein and Connors 2002) and coefficients of variation of less than 0.06 ms (Laurent et al. 2002) . Consistent with this, the EPSCs in our study had latencies which varied by less than 1 ms and a coefficient of variation of 0.046 ± 0.002 (n = 97) identifying them as monosynaptic events. The latencies of the evoked EPSCs showed an age-dependent decline with an average latency from the beginning of the stimulation artifact of 6.09 ± 0.18 ms in slices from mice 10-13 postnatal days old (n = 47) and 3.37 ± 0.09 ms in slices from mice 16-23 postnatal days old (n = 50). These latencies are consistent with the latencies of thalamocortical EPSCs measured in slices from similarly aged animals (Agmon et al. 1996; Agmon and O'Dowd 1992; Crair and Malenka 1995; Laurent et al. 2002; Lu et al. 2001) . It is unlikely that corticothalamic fibers activated antidromically from the thalamus contributed to the responses since corticothalamic EPSCs exhibit paired pulse facilitation (Beierlein and Connors 2002) and the EPSCs that we studied exhibited paired pulse depression (Fig. 5 ) like thalamocortical EPSCs examined in previous studies (Gibson et al. 1999; Gil et al. 1997; Porter et al. 2001 ).
The neuron shown in Figure 1 is an example of an identified layer IV inhibitory neuron from a P11 mouse. In response to depolarizing current pulses, it exhibited spikes with little or no frequency adaptation and large afterhyperpolarizing potentials (AHPs) with a fast repolarization (Fig. 1A) , which is typical of cortical inhibitory neurons (Cauli et al. 1997; Kawaguchi and Kubota 1997; Porter et al. 1999) . Post hoc morphological analysis demonstrates that this cell exhibits a nonpyramidal morphology with aspiny dendrites (Fig. 1B ) confirming its electrophysiological classification as an inhibitory cortical neuron (Meinecke and Peters 1987; Ribak 1978) . Furthermore, in this example the neuron forms putative synaptic contacts with an unlabeled cell body. Such perisomatic synapses are typical of inhibitory cortical basket cells (Kawaguchi and Kubota 1997; Somogyi et al. 1983 ). In the presence of bicuculline and AP5 to block GABA A and NMDA receptors, respectively, stimulation of the ventrobasal nucleus of the thalamus induced thalamocortical EPSCs in this neuron. Bath application of 10 µM baclofen, a selective GABA B receptor agonist, reversibly reduced the amplitude of the thalamocortical EPSCs by 40% (Fig. 1C, D) indicating that thalamic activation of cortical inhibitory circuits is modulated by GABA B receptors.
To test whether baclofen also modulates thalamocortical stimulation of excitatory layer IV neurons similar experiments were done on identified excitatory neurons. The layer IV cell from a P12 mouse shown in Figure 2 exhibited strongly adapting spikes and small and slowly repolarizing AHPs in response to injected current pulses ( Fig. 2A ) and a small cell body with thin radiating spiny dendrites (Fig. 2B) , identifying it as an excitatory spiny stellate cell (Feldmeyer et al. 1999; Porter et al. 2001; Simons and Woolsey 1984) . Bath application of 10 µM baclofen reduced the thalamocortical EPSCs recorded in this neuron by 68% (Fig. 2C, D) demonstrating that baclofen also modulates thalamic stimulation of cortical excitatory circuits. Within the population of neurons examined, the percent inhibition of thalamocortical EPSCs produced by baclofen in inhibitory interneurons (45 ± 8%; n = 12) did not statistically differ from that of excitatory spiny stellate cells (49 ± 6%; n = 13; t-test, p > 0.1; Fig. 2E ).
To confirm that baclofen's effect was mediated through GABA B receptors, a selective GABA B receptor antagonist CGP 35348 (Olpe et al. 1990) 
GABA B receptors modulate thalamic excitation of cortical neurons presynaptically.
The effect of baclofen could be due to stimulation of either presynaptic or postsynaptic GABA B receptors. Presynaptic GABA B receptors inhibit VDCCs to decrease the release of neurotransmitter (Wu and Saggau 1995; Wu and Saggau 1997) , while postsynaptic GABA B receptors generally activate inwardly rectifying K + channels causing hyperpolarization (Luscher et al. 1997; Sodickson and Bean 1996) . Within the population of neurons examined, baclofen did not significantly affect the holding current or the membrane resistance (n = 24; ANOVA, p > 0.05); however, in a few neurons there was a decrease in the holding current and the input resistance consistent with the postsynaptic activation of GABA B receptors (Fig 4A) . These results suggest that baclofen's effect was not mediated postsynaptically. To further determine whether a postsynaptic effect of baclofen produced the reduction in EPSC amplitude we used a Cs + -based recording solution to inhibit the K + currents activated by GABA B receptors (Jarolimek et al. 1994; Morishita and Sastry 1995) . As shown in the example in Figure   4B with Cs + in the patch pipette baclofen reduced thalamocortical EPSCs without changing the holding current or the input resistance. Baclofen did not affect the holding current or membrane resistance of the cells recorded with intracellular Cs + (n = 32; ANOVA; p > 0.05). In the population studied, 10 µM baclofen reduced thalamocortical EPSCs in inhibitory interneurons recorded in the presence of intracellular Cs + by 54 ± 3%
(n = 20) and in excitatory neurons by 49 ± 5% (n = 17). As in experiments without Cs + in the internal solution, the inhibition observed in both cell types was not statistically different (p > 0.1, t-test), so the data from both cell types was grouped for the remaining analyses. As shown in Fig. 4C there was no difference between the percent inhibition produced by baclofen with Cs + in the internal solution (52 ± 3%; n = 37) and without Cs + (47 ± 5%; n = 25; p > 0.1, t-test) suggesting that presynaptic GABA B receptors mediate the reduction in thalamocortical EPSC amplitudes.
To further determine whether baclofen was working pre-or postsynaptically we examined baclofen's effect on the PPR and the CV of the EPSCs. Manipulations that decrease the probability of neurotransmitter release produce an increase in the PPR and in the CV of the EPSCs (Ohana and Sakmann 1998; Zucker 1989) . Typical of thalamocortical synapses (Amitai 2001; Gil and Amitai 1996) , paired stimuli evoked strongly depressing EPSCs (Fig. 5A ). Scaling the average traces taken before and during the perfusion of baclofen, so that the first EPSC is the same amplitude in both traces,
indicates that baclofen increased the PPR from 0.08 to 0.59. An overlay of the 10 consecutive traces used to generate the average traces demonstrates that baclofen also increased the CV from 0.07 to 0.14 ( Although the hyperpolarization of thalamocortical projecting neurons by baclofen could reduce the number of thalamocortical neurons which discharge in response to the stimulation and thus reduce the resultant EPSCs recorded in the cortical neurons, our results are unlikely to be caused by this mechanism since a general inhibition of the thalamocortical neurons should equally affect both the first EPSC and the second EPSC and should; therefore, not affect the PPR of the EPSCs. Furthermore, baclofen reduced thalamocortical EPSCs evoked by stimulating the internal capsule (66 ± 10%, n = 3) which contains only axons (data not shown).
GABA B receptors modulate thalamocortical inputs onto layer II-III pyramidal cells
Since previous results indicated that thalamocortical EPSCs onto layer II-III pyramidal neurons were not modulated by baclofen, our results raised the possibility that thalamocortical synapses in layer IV could be selectively modulated by baclofen. To directly test this possibility, we examined the effects of baclofen on thalamocortical EPSCs onto layer II-III pyramidal neurons from mice 14 to 20 days postnatal. In response to injected current pulses, layer II-III pyramidal neurons exhibited strongly adapting spikes and small and slowly repolarizing AHPs (Fig. 6A ) similar to the excitatory spiny stellate neurons. Post hoc morphological analysis confirmed that the six recorded neurons were layer II-III pyramidal neurons with prominent apical dendrites and dendrites (Fig.   6B ). After recording the response to injected current, the neuron in Figure 6 was repatched with an internal solution containing both Cs + and 1 mM QX-314 to block postsynaptic GABA B receptor-mediated effects. Stimulation of the thalamus evoked EPSCs in the presence of bicuculline and AP5. Consistent with thalamocortical EPSCs the evoked currents exhibited paired pulse depression with a paired pulse ratio of 0.49 ± 0.15 ( Fig. 6E ; n = 6) and latencies that varied by less than 1 ms. The application of 10 µM baclofen reversibly reduced the thalamocortical EPSCs recorded in the layer II-III pyramidal neurons (n = 6) by an average of 74 ± 9% (Fig. 6C-F Therefore, our results are contrary to the previous results (Gil et al. 1997 ). Since the previous study had shown that intracortical inputs were modulated by baclofen, we needed to confirm that we were recording monosynaptic thalamocortical synaptic currents. Based on the fact that the latency of the evoked EPSCs varied by less than 1 ms suggests that they are indeed monosynaptic (Agmon et al. 1996; Beierlein and Connors 2002) . To further confirm that monosynaptic EPSCs evoked by stimulating the thalamus are modulated by baclofen, we examined the effect of baclofen on NMDA receptormediated synaptic currents. Slices were perfused with 10 µM bicuculline and 10 µM CNQX to essentially block synaptic transmission by blocking GABA A and AMPA/kainate receptors, respectively. The thalamus was stimulated and NMDA receptor-mediated synaptic currents were recorded in cortical neurons voltage-clamped at +60 mV to remove the Mg 2+ block of the NMDA receptors. Under these conditions all synaptic transmission except for the monosynaptic input to the recorded neuron should be blocked. Application of 10 µM baclofen reversibly reduced the NMDA receptormediated synaptic currents recorded under these conditions by 73 ± 10% (n = 4; 2 layer IV inhibitory neurons and 2 layer II-III pyramidal neurons; Fig 7A-C) . These experiments further confirm that monosynaptic inputs coming from the thalamus are modulated by GABA B receptors.
Since the previous article (Gil et al. 1997 ) used 1 µM baclofen and we were using 10 µM baclofen, we decided to test the concentration-dependency of the baclofenmediated inhibition of thalamocortical EPSCs. A concentration-response curve generated by applying different concentrations of baclofen gave an EC 50 of 4.4 µM with an average inhibition of only 8 ± 5% produced by 1 µM baclofen (Fig. 7D) . These results are consistent with the EC 50 of baclofen-mediated inhibition of hippocampal EPSCs (Lei and McBain 2003; Wu and Saggau 1995) . Therefore the apparent discrepancy between our results and the previous study can be accounted for by the difference in the concentrations of baclofen.
DISCUSSION
Our main finding is that GABA B receptors on thalamocortical terminals modulate thalamic excitation of cortical neurons in layers II-III and IV. This is an important finding since it provides another mechanism whereby cortical inhibition can modulate the processing of sensory information and perhaps even plasticity, and it is the first demonstration that afferent fibers in the cortex can be modulated by GABA B receptors.
Since baclofen equally inhibited thalamocortical EPSCs onto excitatory and inhibitory 1993; Gil et al. 1997; Zilberter et al. 1999 ).
The results of present study represent the first demonstration that afferents within the cortex can be modulated by presynaptic GABA B receptors. Previous studies have demonstrated that perforant path synapses in the hippocampus (Colbert and Levy 1992) and afferent fibers in the olfactory cortex (Tang and Hasselmo 1994) are not modulated by GABA B receptors. Since baclofen does modulate the intrinsic fibers of both of these brain regions, it has been proposed that GABA B receptors are selectively targeted to the intracortical synaptic terminals (Hasselmo 1995). Based on our results, the models of how GABA B receptors regulate the processing of incoming afferent signals should be modified to include the inhibition of sensory afferents in the primary somatosensory cortex. The structural similarities between the olfactory cortex and the hippocampus (Tang and Hasselmo 1994) suggest the possibility that GABA B receptors may be selectively targeted to intrinsic fibers only in cortical areas which lack the six layer structure of the primary somatosensory cortex. However, the selective modulation of intrinsic fibers in the primary somatosensory cortex may still occur since the intracortical fibers (Gil et al. 1997) were inhibited by lower concentrations of baclofen than the thalamocortical fibers.
In conclusion, our results demonstrate that glutamate release from thalamocortical synapses onto both inhibitory layer IV neurons and excitatory neurons in layers II-III and IV is regulated by the activity of presynaptic GABA B receptors. This mechanism could account for the in vivo observations that indicate that GABA B receptors are involved in the processing of sensory information in the primary somatosensory cortex (Kaneko and Hicks 1988; Kaneko and Hicks 1990) . A reduction in glutamate release from thalamocortical terminals would preferentially suppress weak and longer latency inputs leading to a reduction in receptive field sizes (Chowdhury and Rasmusson 2002a, b; Kyriazi et al. 1996a) . For example the prior stimulation of an adjacent whisker inhibits the cortical response to the principle whisker (Simons 1985; Simons and Carvell 1989) . A recent study indicates that the stimulation of adjacent whiskers reduces the thalamocortical EPSP by a mechanism other than hyperpolarization or shunting inhibition 
